US 8921050
Methods of diagnosing renal cell carcinoma
granted A61KA61K2039/585A61K2239/56
Quick answer
US patent 8921050 (Methods of diagnosing renal cell carcinoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/585, A61K2239/56, A61K35/12, A61K35/17